Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study of Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia That Has Failed Conventional Radiofrequency Ablation

NCT01791543 is registered in ClinicalTrials.gov with William Stevenson as lead sponsor.

NCT NCT01791543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01791543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study of Intramural Needle Ablation for Ablation of Recurrent Ventricular Tachycardia That Has Failed Conventional Radiofrequency Ablation
Lead sponsor
William Stevenson
Phase
Not applicable
Overall status
Completed
Start date
September 30, 2016
Completion date
May 27, 2022
Enrollment
115 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

ventricular tachycardia